NCT01069926View on ClinicalTrials.gov

To Assess the Pharmacokinetics of AZD1656 and Its Metabolite in Type 2 Diabetes Mellitus Patients

PHASE1CompletedINTERVENTIONAL

Enrollment

21

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions

Glucose Lowering

Interventions

DRUG

AZD1656

Single dose oral tablet

Trial Locations (4)

Unknown

Research Site, Orlando

Research Site, Overland Park

Research Site, Minneapolis

Research Site, Knoxville

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY